Laboratory diagnosis of SARS.
Identifieur interne : 000993 ( Ncbi/Merge ); précédent : 000992; suivant : 000994Laboratory diagnosis of SARS.
Auteurs : A. Bermingham [Royaume-Uni] ; P. Heinen ; M. Iturriza-G Mara ; J. Gray ; H. Appleton ; M C ZambonSource :
- Philosophical transactions of the Royal Society of London. Series B, Biological sciences [ 0962-8436 ] ; 2004.
Descripteurs français
- KwdFr :
- Anticorps antiviraux (immunologie), Dosage immunologique (), Humains, Syndrome respiratoire aigu sévère (diagnostic), Syndrome respiratoire aigu sévère (immunologie), Techniques de sonde moléculaire, Tests sérologiques (), Virus du SRAS (génétique), Virus du SRAS (immunologie), Virus du SRAS (physiologie).
- MESH :
- diagnostic : Syndrome respiratoire aigu sévère.
- génétique : Virus du SRAS.
- immunologie : Anticorps antiviraux, Syndrome respiratoire aigu sévère, Virus du SRAS.
- physiologie : Virus du SRAS.
- Dosage immunologique, Humains, Techniques de sonde moléculaire, Tests sérologiques.
English descriptors
- KwdEn :
- MESH :
- chemical , immunology : Antibodies, Viral.
- diagnosis : Severe Acute Respiratory Syndrome.
- genetics : SARS Virus.
- immunology : SARS Virus, Severe Acute Respiratory Syndrome.
- methods : Immunoassay, Serologic Tests.
- physiology : SARS Virus.
- Humans, Molecular Probe Techniques.
Abstract
The emergence of new viral infections of man requires the development of robust diagnostic tests that can be applied in the differential diagnosis of acute illness, or to determine past exposure, so as to establish the true burden of disease. Since the recognition in April 2003 of the severe acute respiratory syndrome coronavirus (SARS-CoV) as the causative agent of severe acute respiratory syndrome (SARS), enormous efforts have been applied to develop molecular and serological tests for SARS which can assist rapid detection of cases, accurate diagnosis of illness and the application of control measures. International progress in the laboratory diagnosis of SARS-CoV infection during acute illness has led to internationally agreed World Health Organization criteria for the confirmation of SARS. Developments in the dissection of the human immune response to SARS indicate that serological tests on convalescent sera are essential to confirm SARS infection, given the sub-optimal predictive value of molecular detection tests performed during acute SARS illness.
DOI: 10.1098/rstb.2004.1493
PubMed: 15306394
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002C24
- to stream PubMed, to step Curation: 002C24
- to stream PubMed, to step Checkpoint: 002C18
Links to Exploration step
pubmed:15306394Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Laboratory diagnosis of SARS.</title><author><name sortKey="Bermingham, A" sort="Bermingham, A" uniqKey="Bermingham A" first="A" last="Bermingham">A. Bermingham</name><affiliation wicri:level="1"><nlm:affiliation>Enteric, Respiratory and Neurological Laboratory, Health Protection Agency Central Public Health Laboratory, 61 Colindale Avenue, London NW9 5HT, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Enteric, Respiratory and Neurological Laboratory, Health Protection Agency Central Public Health Laboratory, 61 Colindale Avenue, London NW9 5HT</wicri:regionArea><wicri:noRegion>London NW9 5HT</wicri:noRegion></affiliation></author><author><name sortKey="Heinen, P" sort="Heinen, P" uniqKey="Heinen P" first="P" last="Heinen">P. Heinen</name></author><author><name sortKey="Iturriza G Mara, M" sort="Iturriza G Mara, M" uniqKey="Iturriza G Mara M" first="M" last="Iturriza-G Mara">M. Iturriza-G Mara</name></author><author><name sortKey="Gray, J" sort="Gray, J" uniqKey="Gray J" first="J" last="Gray">J. Gray</name></author><author><name sortKey="Appleton, H" sort="Appleton, H" uniqKey="Appleton H" first="H" last="Appleton">H. Appleton</name></author><author><name sortKey="Zambon, M C" sort="Zambon, M C" uniqKey="Zambon M" first="M C" last="Zambon">M C Zambon</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2004">2004</date><idno type="RBID">pubmed:15306394</idno><idno type="pmid">15306394</idno><idno type="doi">10.1098/rstb.2004.1493</idno><idno type="wicri:Area/PubMed/Corpus">002C24</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002C24</idno><idno type="wicri:Area/PubMed/Curation">002C24</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002C24</idno><idno type="wicri:Area/PubMed/Checkpoint">002C18</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002C18</idno><idno type="wicri:Area/Ncbi/Merge">000993</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Laboratory diagnosis of SARS.</title><author><name sortKey="Bermingham, A" sort="Bermingham, A" uniqKey="Bermingham A" first="A" last="Bermingham">A. Bermingham</name><affiliation wicri:level="1"><nlm:affiliation>Enteric, Respiratory and Neurological Laboratory, Health Protection Agency Central Public Health Laboratory, 61 Colindale Avenue, London NW9 5HT, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Enteric, Respiratory and Neurological Laboratory, Health Protection Agency Central Public Health Laboratory, 61 Colindale Avenue, London NW9 5HT</wicri:regionArea><wicri:noRegion>London NW9 5HT</wicri:noRegion></affiliation></author><author><name sortKey="Heinen, P" sort="Heinen, P" uniqKey="Heinen P" first="P" last="Heinen">P. Heinen</name></author><author><name sortKey="Iturriza G Mara, M" sort="Iturriza G Mara, M" uniqKey="Iturriza G Mara M" first="M" last="Iturriza-G Mara">M. Iturriza-G Mara</name></author><author><name sortKey="Gray, J" sort="Gray, J" uniqKey="Gray J" first="J" last="Gray">J. Gray</name></author><author><name sortKey="Appleton, H" sort="Appleton, H" uniqKey="Appleton H" first="H" last="Appleton">H. Appleton</name></author><author><name sortKey="Zambon, M C" sort="Zambon, M C" uniqKey="Zambon M" first="M C" last="Zambon">M C Zambon</name></author></analytic><series><title level="j">Philosophical transactions of the Royal Society of London. Series B, Biological sciences</title><idno type="ISSN">0962-8436</idno><imprint><date when="2004" type="published">2004</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibodies, Viral (immunology)</term><term>Humans</term><term>Immunoassay (methods)</term><term>Molecular Probe Techniques</term><term>SARS Virus (genetics)</term><term>SARS Virus (immunology)</term><term>SARS Virus (physiology)</term><term>Serologic Tests (methods)</term><term>Severe Acute Respiratory Syndrome (diagnosis)</term><term>Severe Acute Respiratory Syndrome (immunology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Anticorps antiviraux (immunologie)</term><term>Dosage immunologique ()</term><term>Humains</term><term>Syndrome respiratoire aigu sévère (diagnostic)</term><term>Syndrome respiratoire aigu sévère (immunologie)</term><term>Techniques de sonde moléculaire</term><term>Tests sérologiques ()</term><term>Virus du SRAS (génétique)</term><term>Virus du SRAS (immunologie)</term><term>Virus du SRAS (physiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Viral</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Anticorps antiviraux</term><term>Syndrome respiratoire aigu sévère</term><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>SARS Virus</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Immunoassay</term><term>Serologic Tests</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Molecular Probe Techniques</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Dosage immunologique</term><term>Humains</term><term>Techniques de sonde moléculaire</term><term>Tests sérologiques</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The emergence of new viral infections of man requires the development of robust diagnostic tests that can be applied in the differential diagnosis of acute illness, or to determine past exposure, so as to establish the true burden of disease. Since the recognition in April 2003 of the severe acute respiratory syndrome coronavirus (SARS-CoV) as the causative agent of severe acute respiratory syndrome (SARS), enormous efforts have been applied to develop molecular and serological tests for SARS which can assist rapid detection of cases, accurate diagnosis of illness and the application of control measures. International progress in the laboratory diagnosis of SARS-CoV infection during acute illness has led to internationally agreed World Health Organization criteria for the confirmation of SARS. Developments in the dissection of the human immune response to SARS indicate that serological tests on convalescent sera are essential to confirm SARS infection, given the sub-optimal predictive value of molecular detection tests performed during acute SARS illness.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15306394</PMID><DateCompleted><Year>2004</Year><Month>11</Month><Day>16</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0962-8436</ISSN><JournalIssue CitedMedium="Print"><Volume>359</Volume><Issue>1447</Issue><PubDate><Year>2004</Year><Month>Jul</Month><Day>29</Day></PubDate></JournalIssue><Title>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</Title><ISOAbbreviation>Philos. Trans. R. Soc. Lond., B, Biol. Sci.</ISOAbbreviation></Journal><ArticleTitle>Laboratory diagnosis of SARS.</ArticleTitle><Pagination><MedlinePgn>1083-9</MedlinePgn></Pagination><Abstract><AbstractText>The emergence of new viral infections of man requires the development of robust diagnostic tests that can be applied in the differential diagnosis of acute illness, or to determine past exposure, so as to establish the true burden of disease. Since the recognition in April 2003 of the severe acute respiratory syndrome coronavirus (SARS-CoV) as the causative agent of severe acute respiratory syndrome (SARS), enormous efforts have been applied to develop molecular and serological tests for SARS which can assist rapid detection of cases, accurate diagnosis of illness and the application of control measures. International progress in the laboratory diagnosis of SARS-CoV infection during acute illness has led to internationally agreed World Health Organization criteria for the confirmation of SARS. Developments in the dissection of the human immune response to SARS indicate that serological tests on convalescent sera are essential to confirm SARS infection, given the sub-optimal predictive value of molecular detection tests performed during acute SARS illness.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bermingham</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Enteric, Respiratory and Neurological Laboratory, Health Protection Agency Central Public Health Laboratory, 61 Colindale Avenue, London NW9 5HT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heinen</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Iturriza-Gómara</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Gray</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Appleton</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Zambon</LastName><ForeName>M C</ForeName><Initials>MC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Philos Trans R Soc Lond B Biol Sci</MedlineTA><NlmUniqueID>7503623</NlmUniqueID><ISSNLinking>0962-8436</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007118" MajorTopicYN="N">Immunoassay</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015336" MajorTopicYN="N">Molecular Probe Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012698" MajorTopicYN="N">Serologic Tests</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>23</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>8</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>11</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>8</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15306394</ArticleId><ArticleId IdType="doi">10.1098/rstb.2004.1493</ArticleId><ArticleId IdType="pii">DP8XERF4FKHPPTP8</ArticleId><ArticleId IdType="pmc">PMC1693399</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):311-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15030703</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):304-10</Citation><ArticleIdList><ArticleId IdType="pubmed">15030702</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 1998 Feb 1;101(3):643-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9449698</ArticleId></ArticleIdList></Reference><Reference><Citation>Virus Res. 1999 Apr;60(2):181-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10392726</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol Methods. 2001 Sep;97(1-2):59-66</Citation><ArticleIdList><ArticleId IdType="pubmed">11483217</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 Apr 19;361(9366):1319-25</Citation><ArticleIdList><ArticleId IdType="pubmed">12711465</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1995-2005</Citation><ArticleIdList><ArticleId IdType="pubmed">12671061</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation><ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation><ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2003 May 30;300(5624):1399-404</Citation><ArticleIdList><ArticleId IdType="pubmed">12730501</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 May 24;361(9371):1761-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12781533</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 May 24;361(9371):1767-72</Citation><ArticleIdList><ArticleId IdType="pubmed">12781535</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 May 24;361(9371):1773-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12781536</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 Jul 26;362(9380):263-70</Citation><ArticleIdList><ArticleId IdType="pubmed">12892955</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 2003 Sep;84(Pt 9):2305-15</Citation><ArticleIdList><ArticleId IdType="pubmed">12917450</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2003 Oct;41(10):4521-4</Citation><ArticleIdList><ArticleId IdType="pubmed">14532176</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2003 Oct 10;302(5643):276-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12958366</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 Dec 18;349(25):2468-9</Citation><ArticleIdList><ArticleId IdType="pubmed">14681520</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):176-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15030679</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):294-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15030700</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):327-33</Citation><ArticleIdList><ArticleId IdType="pubmed">15030706</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Royaume-Uni</li></country></list><tree><noCountry><name sortKey="Appleton, H" sort="Appleton, H" uniqKey="Appleton H" first="H" last="Appleton">H. Appleton</name><name sortKey="Gray, J" sort="Gray, J" uniqKey="Gray J" first="J" last="Gray">J. Gray</name><name sortKey="Heinen, P" sort="Heinen, P" uniqKey="Heinen P" first="P" last="Heinen">P. Heinen</name><name sortKey="Iturriza G Mara, M" sort="Iturriza G Mara, M" uniqKey="Iturriza G Mara M" first="M" last="Iturriza-G Mara">M. Iturriza-G Mara</name><name sortKey="Zambon, M C" sort="Zambon, M C" uniqKey="Zambon M" first="M C" last="Zambon">M C Zambon</name></noCountry><country name="Royaume-Uni"><noRegion><name sortKey="Bermingham, A" sort="Bermingham, A" uniqKey="Bermingham A" first="A" last="Bermingham">A. Bermingham</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000993 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000993 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:15306394
|texte= Laboratory diagnosis of SARS.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:15306394" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |